The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Abstract
OBJECTIVES : To examine the rate and predictors of nursing home placement in patients with Parkinson's disease. DESIGN : Four‐year prospective study. SETTING : A population‐based study in western Norway PARTICIPANTS : 178 community‐dwelling subjects with Parkinson's disease. MEASUREMENTS : Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini‐Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed. RESULTS : Forty‐seven patients (26.4%) were admitted to a nursing home during the 4‐year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission. CONCLUSIONS : Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000 .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement.”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [1]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 618
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10 · Cited by 484
Self-citationRisk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 460
A prospective study of long-term care institutionalization among the aged.
Branch, L. G., & Jette, A. M. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1373 · Cited by 440
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413
Self-citationPredictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 393
Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 347
Self-citation
Research works printed but not linked: 2
- Fahn S, 1987, Recent Development in Parkinson's Disease, 153
- 1987, Diagnostic and Statistical Manual of Mental Disorders
Cited by
Sorted by citations
Items 101–200 of 807
Prevalence of Psychotic Symptoms in a Community-Based Parkinson Disease Sample
Mack, J., Rabins, P. V., Anderson, K. E., Goldstein, S. R., Grill, S. E., Hirsch, E. S., Lehmann, S. W., Little, J. T., Margolis, R. L., Palanci, J. M., et al. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31821f1b41 · Cited by 128
Shine, J. M., Handojoseno, A. M. A., Nguyen, T. N., Tran, Y., Naismith, S. L., Nguyen, H. T., & Lewis, S. J. G. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.09.006 · Cited by 133
Treatment of Psychosis and Dementia in Parkinson’s Disease
Goldman, J. G., & Holden, S. K. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0281-2 · Cited by 121
Early Parkinson’s disease and non-motor issues
Chaudhuri, К. R., & Naidu, Y. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5006-1 · Cited by 121
Janzen, J., Ent, D. V. ‘., Lemstra, A. W., Berendse, H. W., Barkhof, F., & Foncke, E. M. J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6149-z · Cited by 120
Nursing home and end-of-life care in Parkinson disease
Safarpour, D., Thibault, D. P., DeSanto, C. L., Boyd, C. M., Dorsey, E. R., Racette, B. A., & Willis, A. W. (2015) · Neurology · doi:10.1212/wnl.0000000000001715 · Cited by 119
Medication impairs probabilistic classification learning in Parkinson's disease
Jahanshahi, M., Wilkinson, L., Gahir, H., Dharminda, A., & Lagnado, D. A. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.12.010 · Cited by 119
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
Biglan, K., Holloway, R. G., McDermott, M., Richard, I. H., & The Parkinson Study Group CALM-PD Investigators (2007) · Neurology · doi:10.1212/01.wnl.0000265593.34438.00 · Cited by 118
Do nonmotor symptoms in Parkinson's disease differ from normal aging?
Krishnan, S., Sarma, G., Sarma, P. S., & Kishore, A. (2011) · Movement Disorders · doi:10.1002/mds.23826 · Cited by 117
Abendroth, M., Lutz, B. J., & Young, M. E. (2012) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2011.10.003 · Cited by 116
Psychiatric aspects of Parkinson’s disease
Grover, S., Somaiya, M. P., Kumar, S., & Avasthi, A. (2014) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.143197 · Cited by 116
Erro, R., Picillo, M., Vitale, C., Amboni, M., Moccia, M., Longo, K., Cozzolino, A., Giordano, F., Rosa, A. D., Michele, G. D., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303419 · Cited by 115
Minor hallucinations in Parkinson disease
Lenka, A., Pagonabarraga, J., Pal, P. K., Bejr‐Kasem, H., & Kulisvesky, J. (2019) · Neurology · doi:10.1212/wnl.0000000000007913 · Cited by 113
Treatment of Psychosis in Parkinson???s Disease
Fernandez, H. H., Trieschmann, M. E., & Friedman, J. H. (2003) · Drug Safety · doi:10.2165/00002018-200326090-00004 · Cited by 113
Presentation and Management of Psychosis in Parkinson’s Disease and Dementia With Lewy Bodies
Weintraub, D. A., & Hurtig, H. I. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07040715 · Cited by 115
Episodic recognition memory and the hippocampus in Parkinson's disease: A review
Das, T., Hwang, J. J., & Poston, K. L. (2018) · Cortex · doi:10.1016/j.cortex.2018.11.021 · Cited by 121
Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis
Weintraub, D. A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.139 · Cited by 112
Effects of Exercise on Non-motor Symptoms in Parkinson’s Disease
Amara, A. W., & Memon, A. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.11.004 · Cited by 110
Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
Goldman, J. G., Weis, H., Stebbins, G. T., Bernard, B. A., & Goetz, C. G. (2012) · Movement Disorders · doi:10.1002/mds.25062 · Cited by 110
Lenka, A., Jhunjhunwala, K. R., Saini, J., & Pal, P. K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.005 · Cited by 106
Foster, E. R., Bedekar, M., & Tickle‐Degnen, L. (2013) · American Journal of Occupational Therapy · doi:10.5014/ajot.2014.008706 · Cited by 118
Sleep Disorders in Patients with Parkinson??s Disease: Epidemiology and Management
Larsen, J. P., & Tandberg, E. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00002 · Cited by 102
Self-citationParkinson Disease Psychosis: Update
Friedman, J. H. (2013) · Behavioural Neurology · doi:10.1155/2013/645429 · Cited by 98
Treatment of Advanced Parkinson's Disease
Varanese, S., Birnbaum, Z. E., Rossi, R. P., & Rocco, A. D. (2010) · Parkinson s Disease · doi:10.4061/2010/480260 · Cited by 100
Merims, D., Shabtai, H., Korczyn, A. D., Peretz, C., Weizman, N., & Giladi, N. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0209-9 · Cited by 99
Morgante, L., Colosimo, C., Antonini, A., Marconi, R., Meco, G., Pederzoli, M., Pontieri, F. E., Cicarelli, G., Abbruzzese, G., Zappulla, S., et al. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300043 · Cited by 99
Cipresso, P., Albani, G., Serino, S., Pedroli, E., Pallavicini, F., Mauro, A., & Riva, G. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00405 · Cited by 103
Erro, R., Picillo, M., Vitale, C., Amboni, M., Moccia, M., Santangelo, G., Pellecchia, M. T., & Barone, P. (2016) · European Journal of Neurology · doi:10.1111/ene.13106 · Cited by 100
Beyond tremor and rigidity: non-motor features of Parkinson’s disease
Löhle, M., Storch, A., & Reichmann, H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0274-1 · Cited by 99
Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative
Ffytche, D. H., Pereira, J. B., Ballard, C. G., Chaudhuri, К. R., Weintraub, D. A., & Aarsland, D. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314832 · Cited by 94
Self-citationImpact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey
Hermanowicz, N. S., Jones, S. A., & Hauser, R. A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s213917 · Cited by 94
Memory, Mood, and Vitamin D in Persons with Parkinson's Disease
Peterson, A. L., Murchison, C., Zabetian, C. P., Leverenz, J. B., Watson, G. S., Montine, T. J., Carney, N., Bowman, G. L., Edwards, K. L., & Quinn, J. F. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130206 · Cited by 93
Zhu, K., van Hilten, J. J., Putter, H., & Marinus, J. (2013) · Movement Disorders · doi:10.1002/mds.25389 · Cited by 93
Neuropsychiatric problems in Parkinson's disease: Comparisons between self and caregiver report
McKinlay, A., Grace, R. C., Dalrymple‐Alford, J. C., Anderson, T. J., Fink, J., & Roger, D. (2008) · Aging & Mental Health · doi:10.1080/13607860802343225 · Cited by 91
Medical Services Utilization and Prognosis in Parkinson Disease: A Population-Based Study
Parashos, S. A., Maraganore, D. M., O'Brien, P. C., & Rocca, W. A. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.9.918 · Cited by 90
Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?
Duncan, G. W., Firbank, M., O'Brien, J. T., & Burn, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25352 · Cited by 94
Pimavanserin: Potential Treatment For Dementia-Related Psychosis
Cummings, J. L., Ballard, C. G., Tariot, P. N., Owen, R., Foff, E. P., Youakim, J. M., Norton, J., & Stankovic, S. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.29 · Cited by 92
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations
Santangelo, G., Trojano, L., Vitale, C., Ianniciello, M., Amboni, M., Grossi, D., & Barone, P. (2007) · Movement Disorders · doi:10.1002/mds.21746 · Cited by 89
The morbid anatomy of dementia in Parkinson’s disease
Kalaitzakis, M. E., & Pearce, R. K. B. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0597-x · Cited by 90
Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers
Dubbelink, K. T. E. O., Hillebrand, A., Twisk, J. W. R., Deijen, J. B., Stoffers, D., Schmand, B. A., Stam, C. J., & Berendse, H. W. (2013) · Neurology · doi:10.1212/wnl.0000000000000034 · Cited by 87
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease?
Erro, R., Santangelo, G., Barone, P., Picillo, M., Amboni, M., Longo, K., Giordano, F., Moccia, M., Allocca, R., Pellecchia, M. T., et al. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988714532015 · Cited by 86
Eversfield, C. L., & Orton, L. D. (2018) · Psychological Medicine · doi:10.1017/s0033291718003161 · Cited by 85
The burden of Parkinson disease (PD) and concomitant comorbidities
Pohar, S. L., & Jones, C. A. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2008.11.006 · Cited by 84
Understanding visual hallucinations: A new synthesis
Collerton, D., Barnes, J., Diederich, N. J., Dudley, R., ffytche, D., Friston, K., Goetz, C. G., Goldman, J. G., Jardri, R., Kulisevsky, J., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105208 · Cited by 83
Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data
van Laar, T., Deyn, P. P. D., Aarsland, D., Barone, P., & Galvin, J. E. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00166.x · Cited by 83
Self-citationReuter, I., Mehnert, S., Sammer, G., Oechsner, M., & Engelhardt, M. (2012) · Journal of Aging Research · doi:10.1155/2012/235765 · Cited by 81
Advances in the treatment of cognitive impairment in P arkinson's disease
Goldman, J. G., & Weintraub, D. A. (2015) · Movement Disorders · doi:10.1002/mds.26352 · Cited by 80
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
Connolly, B. S., & Fox, S. H. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0238-x · Cited by 78
Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease
Llebaria, G., Pagonabarraga, J., Martínez‐Corral, M., García‐Sánchez, C., Pascual‐Sedano, B., Gironell, A., & Kulisevsky, J. (2010) · Movement Disorders · doi:10.1002/mds.23411 · Cited by 79
Understanding the dopaminergic deficits in Parkinson’s disease: Insights into disease heterogeneity
Lewis, S. J. G., & Barker, R. A. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.08.020 · Cited by 78
Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease
Burn, D. J., & McKeith, I. G. (2003) · Movement Disorders · doi:10.1002/mds.10566 · Cited by 77
Synaptic proteins in CSF relate to Parkinson’s disease stage markers
Bereczki, E., Bogstedt, A., Höglund, K., Tsitsi, P., Brodin, L., Ballard, C., Svenningsson, P., & Aarsland, D. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-017-0008-2 · Cited by 72
Self-citationBejr‐Kasem, H., Pagonabarraga, J., Martínez‐Horta, S., Sampedro, F., Marín‐Lahoz, J., Horta‐Barba, A., Aracil‐Bolaños, I., Pérez‐Pérez, J., Boti, M. A., Campolongo, A., et al. (2018) · Movement Disorders · doi:10.1002/mds.27557 · Cited by 76
Multidisciplinary care for people with Parkinson’s disease: the new kids on the block!
Radder, D. L. M., de Vries, N. M., Riksen, N. P., Diamond, S. J., Gross, D. R., Gold, D. R., Heesakkers, J. P. F. A., Henderson, E. J., Hommel, A. L. A. J., Lennaerts, H. H., et al. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1561285 · Cited by 75
Effect of age on geriatric depression scale performance in Parkinson's disease
Weintraub, D. A., Saboe, K., & Stern, M. B. (2007) · Movement Disorders · doi:10.1002/mds.21369 · Cited by 73
Measuring symptom load in Idiopathic Parkinson's disease
Lee, M., Prentice, W. M., Hildreth, A. J., & Walker, R. W. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.11.009 · Cited by 73
Association of specialist involvement and quality of care for Parkinson's disease
Cheng, E. M., Swarztrauber, K., Siderowf, A. D., Eisa, M., Lee, M., Vassar, S. D., Jacob, E. L., & Vickrey, B. G. (2007) · Movement Disorders · doi:10.1002/mds.21311 · Cited by 72
Quetiapine in the treatment of psychosis in Parkinson’s disease
Shotbolt, P., Samuel, M., & David, A. S. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610389656 · Cited by 72
Weerkamp, N. J., Tissingh, G., Poels, P. J. E., Zuidema, S. U., Munneke, M., Koopmans, R. T. C. M., & Bloem, B. R. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12458 · Cited by 71
Burchill, E., Watson, C. J., Fanshawe, J. B., Badenoch, J., Rengasamy, E. R., Ghanem, D. A., Holle, C., Conti, I., Sadeq, M. A., Saini, A., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100870 · Cited by 72
Picillo, M., Erro, R., Amboni, M., Longo, K., Vitale, C., Moccia, M., Pierro, A., Scannapieco, S., Santangelo, G., Spina, E., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.04.023 · Cited by 69
Caregiver-identified needs and barriers to care in Parkinson's disease
Lageman, S. K., Mickens, M., & Cash, T. V. (2015) · Geriatric Nursing · doi:10.1016/j.gerinurse.2015.01.002 · Cited by 69
Obstructive Sleep Apnea and Cognition in Parkinson's disease
Harmell, A. L., Neikrug, A. B., Palmer, B. W., Avanzino, J. A., Liu, L., Maglione, J. E., Natarajan, L., Corey‐Bloom, J., Loredo, J. S., & Ancoli‐Israel, S. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.01.001 · Cited by 69
Auclair‐Ouellet, N., LIEBERMAN, P. H., & Monchi, O. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.014 · Cited by 74
Modeling freezing of gait in Parkinson's disease with a virtual reality paradigm
Shine, J. M., Matar, E., Bolitho, S., Dilda, V., Morris, T. R., Naismith, S. L., Moore, S. T., & Lewis, S. J. G. (2012) · Gait & Posture · doi:10.1016/j.gaitpost.2012.10.026 · Cited by 68
Functional imaging of cognition in Parkinson's disease
Carbon, M., & Marié, R. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000084225.82329.3c · Cited by 68
Seeing ophthalmologic problems in Parkinson disease
Borm, C. D. J. M., Visser, F., Werkmann, M., de Graaf, D., Putz, D., Seppi, K., Poewe, W. H., Vlaar, A. M. M., Hoyng, C. B., Bloem, B. R., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009214 · Cited by 67
Parkinson disease-associated cognitive impairment
(2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00286-x · Cited by 73
Parkinson’s disease and nursing home placement: the economic impact of the need for care
Vossius, C., Nilsen, O. B., & Larsen, J. O. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02380.x · Cited by 70
Self-citationLewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
Baskys, A. (2004) · PubMed · Cited by 67
Hallucinations in Neurodegenerative Diseases
Burghaus, L., Eggers, C., Timmermann, L., Fink, G. R., & Diederich, N. J. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00247.x · Cited by 68
On visual hallucinations and cortical networks: a trans-diagnostic review
Carter, R., & Ffytche, D. H. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7687-6 · Cited by 65
Zarkali, A., McColgan, P., Ryten, M., Reynolds, R. H., Leyland, L., Lees, A. J., Rees, G. E., & Weil, R. S. (2020) · Brain · doi:10.1093/brain/awaa270 · Cited by 58
Camicioli, R. M., Sabino, J., Gee, M., Bouchard, T. P., Fisher, N., Hanstock, C. C., Emery, D. J., & Martin, W. R. W. (2011) · Movement Disorders · doi:10.1002/mds.23700 · Cited by 65
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients
Erro, R., Santangelo, G., Picillo, M., Vitale, C., Amboni, M., Longo, K., di Polidoro, A. C., Pellecchia, M. T., Allocca, R., Rosa, A. D., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6407-0 · Cited by 66
The role of acetylcholine and dopamine in dementia and psychosis in Parkinson’s disease
Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0643-3_11 · Cited by 64
Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease
Barrett, M. J., Blair, J. C., Sperling, S. A., Smolkin, M. E., & Druzgal, T. J. (2018) · Neurology · doi:10.1212/wnl.0000000000005421 · Cited by 63
Management of psychosis in Parkinsonʼs disease
Wolters, E. C., & Berendse, H. W. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00011 · Cited by 63
Kurz, M. W., Dekomien, G., Nilsen, O. B., Larsen, J. P., Aarsland, D., & Alves, G. W. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709332945 · Cited by 62
Self-citationSurviving 10 years with deep brain stimulation for Parkinson's disease – a follow‐up of 79 patients
Henriksen, M. B., Johnsen, E., Sunde, N. A., Vase, A., Gjelstrup, M. C., & Østergaard, K. (2014) · European Journal of Neurology · doi:10.1111/ene.12614 · Cited by 62
Telemedicine for the care of nursing home residents with Parkinson's disease
Biglan, K., Voss, T., Deuel, L. M., Miller, D., Eason, S., Fagnano, M., George, B. P., Appler, A., Polanowicz, J., Viti, L., et al. (2009) · Movement Disorders · doi:10.1002/mds.22498 · Cited by 61
Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia
Zoccolella, S., Dell’Aquila, C., Abruzzese, G., Antonini, A., Bonuccelli, U., Canesi, M., Cristina, S., Marchese, R., Pacchetti, C., Zagaglia, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22511 · Cited by 65
Dujardin, K., Defebvre, L., Duhamel, A., Lecouffe, P., Rogelet, P., Steinling, M., & Dest�e, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0549-2 · Cited by 60
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
Goldman, J. G., Stebbins, G. T., Bernard, B. A., Stoub, T. R., Goetz, C. G., & deToledo‐Morrell, L. (2012) · Movement Disorders · doi:10.1002/mds.24938 · Cited by 63
Dorsey, E. R., Achey, M. A., Beck, C. A., Beran, D. B., Biglan, K., Boyd, C. M., Schmidt, P. N., Simone, R. B., Willis, A. W., Galifianakis, N. B., et al. (2016) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2015.0191 · Cited by 60
Meles, S. K., Tang, C. C., Teune, L. K., Dierckx, R., DHAWAN, V. M., Mattis, P. J., Leenders, K. L., & Eidelberg, D. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.112 · Cited by 59
Goetz, C. G., Fan, W., & Leurgans, S. E. (2008) · Movement Disorders · doi:10.1002/mds.22132 · Cited by 61
Atypical Antipsychotics in Parkinson-Sensitive Populations
Friedman, J. H., & Fernandez, H. H. (2002) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870201500307 · Cited by 58
Non-Motor Symptoms of Parkinson's Disease: Diagnosis and Management
Salawu, F., Danburam, A., & Olokoba, A. (2010) · Nigerian Journal of Medicine · doi:10.4314/njm.v19i2.56496 · Cited by 58
Visual Dysfunction in Parkinson’s Disease
Nieto-Escámez, F. A., Obrero‐Gaitán, E., & Cortés‐Pérez, I. (2023) · Brain Sciences · doi:10.3390/brainsci13081173 · Cited by 67
Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study
Pirogovsky‐Turk, E., Moore, R. C., Filoteo, J. V., Litvan, I., Song, D. D., Lessig, S. L., & Schiehser, D. M. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.10.004 · Cited by 65
Mind the gaps: What we don't know about cognitive impairment in essential tremor
Louis, E. D., Joyce, J. L., & Cosentino, S. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.038 · Cited by 58
Cognitive Change in Parkinson Disease
Galvin, J. E. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213858.27731.f8 · Cited by 57
Camicioli, R. M., Rajput, A. H., Rajput, M., Reece, C., Payami, H., Hao, C., & Rajput, A. H. (2005) · Movement Disorders · doi:10.1002/mds.20481 · Cited by 57
New Wine in Old Bottle: Late-Life Psychosis
Iglewicz, A., Meeks, T. W., & Jeste, D. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.02.008 · Cited by 38
Hindle, J. V., Watermeyer, T., Roberts, J., Brand, A., Hoare, Z., Martyr, A., & Clare, L. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4845 · Cited by 56
Suicide in Parkinson’s disease
Shepard, M. D., Perepezko, K. M., Broen, M. P. G., Hinkle, J. T., Butala, A., Mills, K. A., Nanavati, J., Fischer, N. M., Nestadt, P. S., & Pontone, G. M. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319815 · Cited by 55
Non-motor features of Parkinson's disease: depression and dementia
Reichmann, H., Schneider, C. B., & Löhle, M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70789-8 · Cited by 54
Treatment of psychotic symptoms in patients with Parkinson disease
Chen, J. J. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.11.262 · Cited by 55
Espay, A. J., Guskey, M. T., Norton, J. C., Coate, B., Vizcarra, J. A., Ballard, C. G., Factor, S. A., Friedman, J. H., Lang, A. E., Larsen, N. J., et al. (2018) · Movement Disorders · doi:10.1002/mds.27488 · Cited by 56
Metadata
- Authors
- Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K.
- Affiliations
- Stavanger University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Aarsland, Dag
- ORCID
- Aarsland, Dag
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 48
- Issue
- 8
- Pages
- 938-942
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2083220625
- Cited by
- 811
- References
- 21
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 30 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 64 · 2019: 36 · 2018: 35 · 2017: 36 · 2016: 37 · 2015: 32 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Geriatrics Society (publishedVersion)
- PubMed (publishedVersion)
- Journal of the American Geriatrics Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, nursing home admission, institutionalization, predictors of institutionalization, hallucinations, dementia, functional disability, activities of daily living, motor symptoms, neuropsychiatric symptoms, depression, community-dwelling patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Dementia, Female, Hallucinations, Humans, Male, Middle Aged, Norway, Nursing Homes, Parkinson Disease, Patient Admission, Predictive Value of Tests, Prospective Studies, Psychiatric Status Rating Scales, Risk Factors, Severity of Illness Index, Geriatric Assessment, Linear Models, Proportional Hazards Models, Age Distribution, Community Health Planning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review